236 related articles for article (PubMed ID: 11988932)
1. Prevalence of p53, bcl-2, and Ki-67 immunoreactivity and of apoptosis in normal oral epithelium and in premalignant and malignant lesions of the oral cavity.
Piattelli A; Rubini C; Fioroni M; Iezzi G; Santinelli A
J Oral Maxillofac Surg; 2002 May; 60(5):532-40. PubMed ID: 11988932
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study of syndecan-1 down-regulation and the expression of p53 protein or Ki-67 antigen in oral leukoplakia with or without epithelial dysplasia.
Kurokawa H; Matsumoto S; Murata T; Yamashita Y; Tomoyose T; Zhang M; Fukuyama H; Takahashi T
J Oral Pathol Med; 2003 Oct; 32(9):513-21. PubMed ID: 12969225
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas.
Shintani S; Yoshihama Y; Emilio AR; Matsumura T
Anticancer Res; 1995; 15(2):305-8. PubMed ID: 7762998
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical study of p21 and Bcl-2 in leukoplakia, oral submucous fibrosis and oral squamous cell carcinoma.
Sutariya RV; Manjunatha BS
J Exp Ther Oncol; 2016 Nov; 11(4):285-292. PubMed ID: 27849339
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of p53 and bcl-2 oncoprotein expression in precancerous lesions of the oral cavity.
Sulkowska M; Famulski W; Chyczewski L; Sulkowski S
Neoplasma; 2001; 48(2):94-8. PubMed ID: 11478700
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
[TBL] [Abstract][Full Text] [Related]
7. The overexpression of p53 and proliferative activity in precancerous and cancerous lesions of oral squamous epithelium.
Ichikawa M; Ishii K; Nakajima T; Mogi K
J Exp Clin Cancer Res; 1997 Jun; 16(2):141-6. PubMed ID: 9261738
[TBL] [Abstract][Full Text] [Related]
8. Histopathological and immunohistochemical study of malignant transformation of oral leukoplakia, with special reference to apoptosis-related gene products and proliferative activity.
Nogami T; Kuyama K; Yamamoto H
Acta Otolaryngol; 2003 Aug; 123(6):767-75. PubMed ID: 12953781
[TBL] [Abstract][Full Text] [Related]
9. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
[TBL] [Abstract][Full Text] [Related]
10. Expression of p53 in oral mucosal hyperplasia, dysplasia and squamous cell carcinoma.
Kerdpon D; Rich AM; Reade PC
Oral Dis; 1997 Jun; 3(2):86-92. PubMed ID: 9467348
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of p53, caspase-3, Bcl-2, and Ki-67 markers in oral squamous cell carcinoma and premalignant epithelium in a sample from Alava Province (Spain).
Bascones-Martínez A; Rodríguez-Gutierrez C; Rodríguez-Gómez E; Gil-Montoya JA; Gómez-Font R; González-Moles MÁ
Med Oral Patol Oral Cir Bucal; 2013 Nov; 18(6):e846-50. PubMed ID: 23722133
[TBL] [Abstract][Full Text] [Related]
12. Midkine expression in oral squamous cell carcinoma and leukoplakia.
Jham BC; Costa NL; Silva JM; de Miranda AC; Oliveira JC; Silva TA; Batista AC
J Oral Pathol Med; 2012 Jan; 41(1):21-6. PubMed ID: 21595751
[TBL] [Abstract][Full Text] [Related]
13. Aberrant expression of p53, p16INK4a and Ki-67 as basic biomarker for malignant progression of oral leukoplakias.
Nasser W; Flechtenmacher C; Holzinger D; Hofele C; Bosch FX
J Oral Pathol Med; 2011 Sep; 40(8):629-35. PubMed ID: 21435003
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of the p53 tumor-suppressor gene product in oral leukoplakia.
Wood MW; Medina JE; Thompson GC; Houck JR; Min KW
Otolaryngol Head Neck Surg; 1994 Dec; 111(6):758-63. PubMed ID: 7527509
[TBL] [Abstract][Full Text] [Related]
15. Increased subepithelial vascularization and VEGF expression reveal potentially malignant changes in human oral mucosa lesions.
Gandolfo M; Keszler A; Lanfranchi H; Itoiz ME
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Apr; 111(4):486-93. PubMed ID: 21420637
[TBL] [Abstract][Full Text] [Related]
16. [Bcl-2, p53, Ki-67 and apoptotic index in cancerous and precancerous lesions of the oral mucosa].
Tetè S; Pappalardo S; Fioroni M; Salini L; Imperatrice AM; Perfetti G
Minerva Stomatol; 1999 Sep; 48(9):419-25. PubMed ID: 10638175
[TBL] [Abstract][Full Text] [Related]
17. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Girod SC; Pfeiffer P; Ries J; Pape HD
Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
[TBL] [Abstract][Full Text] [Related]
18. [Expression of integrin-linked kinase in oral leukoplakia and early invasive carcinoma].
Guo ZL; Gao Y
Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Mar; 45(3):163-7. PubMed ID: 20450685
[TBL] [Abstract][Full Text] [Related]
19. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]